Vortex keratopathy associated with ribociclib.

Türkel, Alper; Özdogan, Sibel; Yekedüz, Emre; Seyran, Erdogan; Karaçin, Cengiz; Ates, Öztürk

Türkel, Alper; Özdogan, Sibel; Yekedüz, Emre; Seyran, Erdogan; Karaçin, Cengiz; Ates, Öztürk.

Afiliação

Türkel A; Division of Medical Oncology, 146995Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
Özdogan S; Division of Ophthalmology, 146995Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
Yekedüz E; Division of Medical Oncology, 146995Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
Seyran E; Division of Medical Oncology, 146995Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
Karaçin C; Division of Medical Oncology, 146995Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
Ates Ö; Division of Medical Oncology, 146995Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.

J Oncol Pharm Pract ; 29(1): 230-232, 2023 Jan.

Article em En | MEDLINE | ID: mdl-35570741

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica; Neoplasias da Mama; Humanos; Feminino; Idoso; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos; Aminopiridinas/efeitos adversos; Receptor ErbB-2/metabolismo; Purinas/efeitos adversos; Neoplasias da Mama/patologia

Palavras-chave

Ribociclib; breast cancer; combination treatment; cyclin-dependent kinases 4 and 6; vortex keratopathy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google